Sanofi

Latest news

• Sanofi pays Regeneron USD 1bn upfront in immunology deal (opens in a new tab)

  medwatch.com · Oct 2, 2026

• Friday Five: Sanofi and Regeneron (re)partner up in the face of Dupixent's patent cliff, AstraZeneca invests $2B in Summit, Lilly delivers more weight loss wins…and more (opens in a new tab)

  FirstWord Pharma · Oct 2, 2026

• Sanofi and Regeneron expand alliance with $8bn immunology deal (opens in a new tab)

  BioXconomy · Oct 1, 2026

• Regeneron, Sanofi Expand Alliance in Deal Worth Up to $8 Billion (opens in a new tab)

  MarketBeat · Oct 1, 2026

• Sanofi Puts Up $1B to Expand Regeneron Alliance and Develop Next-Gen Dupixent (opens in a new tab)

  MedCity News · Oct 1, 2026

• Sanofi To Pay Regeneron Up To $8B In Immunology Alliance (opens in a new tab)

  Law360 · Oct 1, 2026

• Sanofi And Regeneron Expand Immunology Alliance In Deal Worth Up To $8 Billion (opens in a new tab)

  Pulse 2.0 · Oct 1, 2026

• REGN Stock In Focus: Sanofi Expands Immunology Deal With $1B Upfront Payment And 4 New Antibodies (opens in a new tab)

  Stocktwits · Oct 1, 2026

• Regeneron And Sanofi Announce A Win-Win Collaboration Expansion (NASDAQ:REGN) (opens in a new tab)

  Seeking Alpha · Oct 1, 2026

• Sanofi, Regeneron expand tie-up with $8 billion drug-development deal, settle legal dispute (opens in a new tab)

  The Lufkin Daily News · Oct 1, 2026

• Sanofi and Regeneron expand global alliance (opens in a new tab)

  The Pharma Letter · Oct 1, 2026

• Sanofi, Regeneron deepen decadeslong alliance with $8B deal (opens in a new tab)

  Axios · Oct 1, 2026

• Regeneron, Sanofi Expand Alliance with $1 Billion Upfront, 4 Antibodies (opens in a new tab)

  BioPharm International · Oct 1, 2026

• Four long-acting antibodies anchor Sanofi (SNY)'s expanded alliance with Regeneron. (opens in a new tab)

  Stock Titan · Oct 1, 2026

• Sanofi, Regeneron broaden alliance to find their next Dupixent (opens in a new tab)

  BioPharma Dive · Oct 1, 2026

• Spotlight On: Sanofi and Regeneron get cosy again as they look to build on Dupixent success (opens in a new tab)

  FirstWord Pharma · Oct 1, 2026

• Sanofi Deepens 20-Year Drug Development Pact With Regeneron, Pledges Up to $8 Billion (opens in a new tab)

  Benzinga · Oct 1, 2026

• Regeneron and Sanofi Expand Antibody Alliance with Four New Drugs (opens in a new tab)

  Pharmaceutical Executive · Oct 1, 2026

• Sanofi, Regeneron to Expand Alliance in Up to $8 Billion Deal (opens in a new tab)

  WSJ · Oct 1, 2026

• Sanofi, Regeneron Expand DUPIXENT Alliance in Deal Worth Up to €8 Billion (opens in a new tab)

  Yahoo Finance · Oct 1, 2026

• Sanofi, Regeneron expand partnership after Dupixent success (opens in a new tab)

  STAT · Oct 1, 2026

• Sanofi pays $1B upfront to expand immunology deal with Regeneron (opens in a new tab)

  FirstWord Pharma · Oct 1, 2026

• Sanofi pays Regeneron $1B upfront to continue search for Dupixent successor (opens in a new tab)

  biospace.com · Oct 1, 2026

• Sanofi commits up to USD 8b for Regeneron’s long-acting immunology antibodies (opens in a new tab)

  allsci.com · Oct 1, 2026

• Sanofi forges new $8bn pact with Regeneron (opens in a new tab)

  pharmaphorum · Oct 1, 2026

• Sanofi and Regeneron expand immunology partnership to the tune of $8bn (opens in a new tab)

  Pharmaceutical Technology · Oct 1, 2026

• Sanofi to invest up to $8bn to expand alliance with Regeneron (opens in a new tab)

  marketscreener.com · Oct 1, 2026

• Sanofi builds on immunology alliance with Regeneron for $1B upfront (opens in a new tab)

  endpoints.news · Oct 1, 2026

• Sanofi pays $1B upfront to expand Regeneron alliance beyond Dupixent (opens in a new tab)

  European Biotechnology Magazine · Oct 1, 2026

• Sanofi gains after expanding Regeneron partnership with $8 billion deal (opens in a new tab)

  Investing.com · Oct 1, 2026